title: Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study): How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?
authors: From the Department of Neurology, Helsinki University Central Hospital, Finland (D.S.); Stroke Outcomes Research Unit, Division of Neurology, Department of Medicine (G.S.) and Li Ka Shing Knowledge Institute (G.S.), St. Michael's Hospital, University of Toronto, Ontario, Canada; and Neuroeconomics and Social Neuroscience, Department of Economics, University of Zurich, Switzerland (G.S.). daniel.strbian@hus.fi.
authors: Daniel
authors: D
authors: Strbian
authors: From the Department of Neurology, Helsinki University Central Hospital, Finland (D.S.); Stroke Outcomes Research Unit, Division of Neurology, Department of Medicine (G.S.) and Li Ka Shing Knowledge Institute (G.S.), St. Michael's Hospital, University of Toronto, Ontario, Canada; and Neuroeconomics and Social Neuroscience, Department of Economics, University of Zurich, Switzerland (G.S.).
authors: Gustavo
authors: G
authors: Saposnik
mesh_terms: D061605:Administration, Intravenous; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000150:complications / Q000628:therapy*; D013345:Subarachnoid Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology*; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
keywords: angiography; blood pressure; clinical trial; review; stroke